Curtis Cooper

17.8k citations
428 papers · 14.0k · 6 hit papers · h-index 55

Impact in

  • Hepatology top 0.1%
    • Hepatitis C virus research
    • HIV/AIDS Research and Interventions
    • HIV/AIDS drug development and treatment

Papers in

    • Hepatitis C virus research 181
    • HIV/AIDS Research and Interventions 45
    • HIV/AIDS drug development and treatment 36
    • SARS-CoV-2 and COVID-19 Research 33

Curtis Cooper

402 papers receiving 13.5k citations

Curtis Cooper's Hit Papers

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection 2017 · 449 citations
4490+6+13Years since publication250500750

Peers

Curtis Cooper
Comparison fields: 5 of 163
  • Hepatology 5.7k
  • Infectious Diseases 4.3k
  • Virology 952
  • Epidemiology 5.1k
  • Emergency Medicine 675
Replace Gregory J. Dore with:
Gregory J. Dore Australia
Enos Bernasconi Switzerland
Gregory K. Robbins United States
Anne C. Moorman United States
Hansjakob Furrer Switzerland
Diana M. Brainard United States
Matthew Bidwell Goetz United States
Jules L. Dienstag United States
Kelly A. Gebo United States
Matthias L. Cavassini Switzerland
Curtis Cooper relative to Gregory J. Dore Australia Gregory J. Dore's profile →
Citations per field
00.5×1.5×
Gregory J. Dore · 1×
Citations per year

Countries citing papers authored by Curtis Cooper

Since Specialization
Citations

This map shows the geographic impact of Curtis Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtis Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtis Cooper more than expected).

Fields of papers citing papers by Curtis Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curtis Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtis Cooper. The network helps show where Curtis Cooper may publish in the future.

Co-authors

The 25 scholars most cited alongside Curtis Cooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Curtis Cooper Line = papers co-authored together Curtis Cooper links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 428 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Adherence to Antiretroviral Therapy in Sub-Saharan Africa and North America
Hit paper breakdown →
2006753
2
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Hit paper breakdown →
2015697
3
Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators
Hit paper breakdown →
2006649
4
ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Hit paper breakdown →
2014588
5
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Hit paper breakdown →
2017449
6
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Hit paper breakdown →
2015386
7 2011350
8 2011337
9 2004294
10 2018233
11 2016228
12 2004218
13 2015205
14 2005199
15 2005171
16 2013159
17 2019149
18 2003130
19 2011121
20 2012119

About Curtis Cooper

Curtis Cooper is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Virology and Immunology, having authored 428 papers that have together received 14.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (181 papers), Hepatitis B Virus Studies (73 papers), Liver Disease Diagnosis and Treatment (60 papers), HIV/AIDS Research and Interventions (45 papers), HIV/AIDS drug development and treatment (36 papers), SARS-CoV-2 and COVID-19 Research (33 papers), Influenza Virus Research Studies (18 papers) and HIV Research and Treatment (18 papers). The work is most often cited by research in Hepatology (5.7k citations), Infectious Diseases (4.3k citations), Virology (952 citations), Epidemiology (5.1k citations) and Emergency Medicine (675 citations). Curtis Cooper has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Edward J. Mills, D. William Cameron, Jean Bisimwa Nachega, Marina B. Klein, Beth Rachlis, Kumanan R Wilson, Sonal Singh, Iain Edward Buchan, David R. Bangsberg and Robert S. Hogg. Their work appears in journals such as Clinical Infectious Diseases, AIDS, Journal of Hepatology, HIV Medicine and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact